Serveur d'exploration MERS - Exploration (Accueil)

Index « Teeft.i » - entrée « Human immunodeficiency virus »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Human immunode_ciency virus type < Human immunodeficiency virus < Human immunodeficiency virus infection  Facettes :

List of bibliographic references indexed by Human immunodeficiency virus

Number of relevant bibliographic references: 43.
Ident.Authors (with country if any)Title
002A79 (2008) Gopala Rishna Darbha ; Uma Shanker Rai ; Anant Umar Singh ; Paresh Handra Ray [États-Unis]Gold‐Nanorod‐Based Sensing of Sequence Specific HIV‐1 Virus DNA by Using Hyper‐Rayleigh Scattering Spectroscopy
003737 (2000) Zachary Q. Beck ; Laurence Hervio ; Philip E. Dawson ; John H. Elder ; Edwin L. MadisonIdentification of Efficiently Cleaved Substrates for HIV-1 Protease Using a Phage Display Library and Use in Inhibitor Development
003739 (2000) Johan K. Sandberg [Suède] ; Ann-Charlotte Leandersson [Suède] ; Claudia Devito [Suède] ; Birgit Kohleisen [Allemagne] ; Volker Erfle [Allemagne] ; Adnane Achour [Suède] ; Michael Levi [Suède] ; Stefan Schwartz [Suède] ; Klas K Rre [Suède] ; Britta Wahren [Suède] ; Jorma Hinkula [Suède]Human Immunodeficiency Virus Type 1 Nef Epitopes Recognized in HLA-A2 Transgenic Mice in Response to DNA and Peptide Immunization
003B14 (1998) Jonathan L. Heeney [Pays-Bas] ; Mariëlle E. Van Gils [Pays-Bas] ; Peter Van Der Meide [Pays-Bas] ; Carlo De Giuli Morghen [Italie] ; Cristina Ghioni [Italie] ; Margherita Gimelli [Italie] ; Antonio Raddelli [Italie] ; David Davis [Belgique] ; Lennart Akerblom [Suède] ; Bror Morein [Suède]The role of type‐1 and type‐2 T‐helper immune responses in HIV‐1 vaccine protection
003B30 (1998) Dawn P. Wooley ; Lisa A. Bircher ; Randall A. SmithRetroviral Recombination Is Nonrandom and Sequence Dependent
003C89 (1997) Linda Tan [Royaume-Uni] ; Mads Hald Andersen [Danemark] ; Tim Elliott [Royaume-Uni] ; John S. Haurum [Danemark]An improved assembly assay for peptide binding to HLA-B*2705 and H-2Kk class I MHC molecules
003D27 (1997) S. Yamano [Japon] ; J N Renard [Japon] ; F. Mizuno [Japon] ; Y. Narita [Japon] ; Y. Uchida [Japon] ; H. Higashiyama [Japon] ; H. Sakurai [Japon] ; I. Saito [Japon]Retrovirus in salivary glands from patients with Sjögren's syndrome.
003D98 (1997) Sharon M. Richner [Afrique du Sud] ; Jill Meiring [Afrique du Sud] ; Ralph Kirby [Afrique du Sud]A study of the genetic diversity of Mycobacterium tuberculosis isolated from patients in the eastern province of South Africa using random amplified polymorphic DNA profiling
003E51 (1996) Jj Toulmé [France] ; R. Le Tinévez [France] ; E. Brossalina [France]Targeting RNA structures by antisense oligonucleotides
003F87 (1996) Denise L. Doolan [États-Unis] ; Benjamin Wizel [États-Unis] ; Stephen L. Hoffman [États-Unis]Class I HLA-restricted cytotoxic T lymphocyte responses against malaria-elucidation on the basis of HLA peptide binding motifs
004102 (1995) Sang-Gug Kim [Japon] ; Toshifumi Hatta [Japon] ; Satoru Tsukahara [Japon] ; Hideki Nakashima [Japon] ; Naoki Yamamoto [Japon] ; Yoko Shoji [Japon] ; Kazuyuki Takai [Japon] ; Hiroshi Takaku [Japon]Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus
004103 (1995) Makoto Matsukura [Japon] ; Kazuo Koike [Japon] ; Gerald Zon [États-Unis]Antisense phosphorothioates as antivirals against human immunodeficiency virus (HIV) and hepatitis B virus (HBV)
004121 (1995) L. E. Brown [Australie] ; D. O. White [Australie] ; C. Agius [Australie] ; B. E. Kemp ; N. Yatzakis [Australie] ; P. Poumbourios ; D. A. Mcphee [Australie] ; D. C. Jackson [Australie]Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses
004137 (1995) Robert S. Root-Bernstein [États-Unis] ; Sheila Hobbs Dewitt [États-Unis]Semen alloantigens and lymphocytotoxic antibodies in AIDS and ICL
004171 (1995) Ruiwen Zhang [États-Unis] ; Zhihong Lu [États-Unis] ; Hui Zhao [États-Unis] ; Xueshu Zhang [États-Unis] ; Robert B. Diasio [États-Unis] ; Ivan Habus [États-Unis] ; Zhiwei Jiang [États-Unis] ; Radhakrishnan P. Iyer [États-Unis] ; Dong Yu [États-Unis] ; Sudhir Agrawal [États-Unis]In vivo stability, disposition and metabolism of a “hybrid” oligonucleotide phosphorothioate in rats
004226 (1995) Hao Yu [États-Unis] ; John G. Bruno [États-Unis] ; Tu-Chen Cheng [États-Unis] ; Jon J. Calomiris [États-Unis] ; Michael T. Goode [États-Unis] ; Deborah L. Gatto-Menking [États-Unis]A comparative study of PCR product detection and quantitation by electrochemiluminescence and fluorescence
004312 (1994) J. A. Grasby [Royaume-Uni] ; M. J. Gait [Royaume-Uni]Synthetic oligoribonucleotides carrying site-specific modifications for RNA structure-function analysis
004313 (1994) Olivier Zelphati [France] ; Ernst Wagner [Autriche] ; Lee Leserman [France]Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester antisense oligonucleotides incorporated into immunoliposomes
004317 (1994) John Cason [Royaume-Uni]Strategies for mapping and imitating viral B-cell epitopes
004409 (1994) T. Hanke [Royaume-Uni] ; R. E. Randall [Royaume-Uni]Processing of viral proteins for presentation by molecules of the major histocompatibility complex
004412 (1994) D. Archambault [Canada] ; C. A. Stein [États-Unis] ; J. S. Cohen [États-Unis]Phosphorothioate oligonucleotides inhibit the replication of lentiviruses and type D retroviruses, but not that of type C retroviruses
004570 (1993) F. P. Svinarchuk [Russie] ; D. A. Konevetz [Russie] ; O. A. Pliasunova [Russie] ; A. G. Pokrovsky [Russie] ; V. V. Vlassov [Russie]Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups
004581 (1993) Kamel Mabrouk [France] ; Maxime Moulard [France] ; Jean Claude Gluckman [France] ; Régine Romi [France] ; Hervé Rochat [France] ; Jurphaas Van Rietschoten [France] ; Elmostafa Bahraoui [France]Evaluation of structure-antigenicity relationship of peptides from human immunodeficiency virus type 1 (HIV-1) p18 protein by circular dichroism
004744 (1992) Ph Duesberg [États-Unis]The role of drugs in the origin of AIDS
004758 (1992) C. A. Stein [États-Unis] ; John L. Tonkinson [États-Unis] ; Leonid Yakubov [Russie]Phosphorothioate oligodeoxynucleotides—anti-sense inhibitors of gene expression?
004759 (1992) Jack S. Cohen [États-Unis]Oligonucleotides as therapeutic agents
004788 (1992) Derek Kinchington [Royaume-Uni] ; Sarah Galpin [Royaume-Uni] ; Jerzy W. Jaroszewski [Danemark] ; Krishna Ghosh [États-Unis] ; Chrisanthi Subasinghe [États-Unis] ; Jack S. Cohen [États-Unis]A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1
004824 (1992) A. Ebersold [France] ; V. Boyer [France] ; P. J. Klasse [Suède] ; M. Holnigue [France] ; C. Fraisier [France] ; J. M. Cocchi [France] ; R. Pipkorn [Allemagne] ; J. Blomberg [Suède] ; C. Desgranges [France]Human and murine monoclonal antibodies directed against a conserved sequence from gp41 (aa583–599) of human immunodeficiency virus type 1
004825 (1992) Tramontano Enzo [États-Unis] ; Cheng Yung-Chi [États-Unis]HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587
004910 (1991) Ryszard Kole [États-Unis] ; Ram R. Shukla [États-Unis] ; Saghir Akhtar [États-Unis]Pre-mRNA splicing as a target for antisense oligonucleotides
004925 (1991) Katherine A. Staskus [États-Unis] ; Ernest F. Retzel [États-Unis] ; Elizabeth D. Lewis [États-Unis] ; Janet L. Silsby [États-Unis] ; S. T. Sheila Cyr [États-Unis] ; Jeffrey M. Rank [États-Unis] ; Steven W. Wietgrefe [États-Unis] ; Ashley T. Haase [États-Unis] ; Ronald Cook [États-Unis] ; David Fast [États-Unis] ; Paul T. Geiser [États-Unis] ; John T. Harty [États-Unis] ; Selene H. Kong [États-Unis] ; Carol J. Lahti [États-Unis] ; Thomas P. Neufeld [États-Unis] ; Thomas E. Porter [États-Unis] ; Elizabeth Shoop [États-Unis] ; Karen R. Zachow [États-Unis]Isolation of replication-competent molecular clones of visna virus
004950 (1991) Sudhir Agrawal [États-Unis] ; Prem S. Sarin [États-Unis]Antisense oligonucleotides: gene regulation and chemotherapy of AIDS
004951 (1991) Jack S. Cohen [États-Unis]Antisense oligodeoxynucleotides as antiviral agents
004954 (1991) Seth Lederman [États-Unis] ; Julie A. Demartino [États-Unis] ; Bruce L. Daugherty [États-Unis] ; Ivan Foeldvari [États-Unis] ; Michael J. Yellin [États-Unis] ; Aileen M. Cleary [États-Unis] ; Noah Berkowitz [États-Unis] ; Israel Lowy [États-Unis] ; Ned S. Braunstein [États-Unis] ; George E. Mark [États-Unis] ; Leonard Chess [États-Unis]A single amino acid substitution in a common african allele of the CD4 molecule ablates binding of the monoclonal antibody, OKT4
004957 (1991) Per Johan Klasse [Suède] ; Rüdiger Pipkorn [Allemagne] ; Jonas Blomberg [Suède]A cluster of continuous antigenic structures in the transmembrane protein of HIV-1: Individual patterns of reactivity in human sera
004A44 (1990) Lynn Rasmussen [États-Unis] ; Jane K. Battles [États-Unis] ; Willis H. Ennis [États-Unis] ; Kunio Nagashima [États-Unis] ; Matthew A. Gonda [États-Unis]Characterization of virus-like particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus
004A65 (1990) Gerald Zon [États-Unis]Innovations in the Use of Antisense Oligonucleotides
004A69 (1990) S. M. Bruisten ; M. Tersmette ; M. R. Wester ; A. H. V. Vos ; M. H. G. M. Koppelman ; Johannes G. Huisman [Pays-Bas]Efficiency of white cell filtration and a freeze‐thaw procedure for removal of HIV‐infected cells from blood
004B12 (1989) Andreas Meyerhans [France] ; Rémi Cheynier [France] ; Jan Albert [Suède] ; Martina Seth [France] ; Shirley Kwok [États-Unis] ; John Sninsky [États-Unis] ; Linda Morfeldt-M Nson [Suède] ; Birgitta Asjö [Suède] ; Simon Wain-Hobson [France]Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations
004B20 (1989) M. BillstromPreliminary studies towards the development of a subunit cytomegalovirus vaccine
004B30 (1989) D. Y. Sia ; P. Mascagni ; A. R. M. CoatesImmune responses to a 104-mer synthetic peptide of the major internal protein, gag (p24) of the human immunodeficiency virus (HIV-1)
004B31 (1989) S. W. Pyle ; B. Morein ; J. W. Bess Jr. ; P. L. Nara ; S. M. Nigida ; N. W. Lerche ; R. C. Gallo ; P. J. Fischinger ; L. O. ArthurImmune response to immunostimulatory complexes prepared from human immunodeficiency virus and the external envelope glycoprotein
004B34 (1989) David Evans ; Jane Mckeating ; Karen Burke ; Owen Jenkins ; Alison Gillen ; Janet Meredith ; Philip Minor ; Jeffery AlmondHIV-1 epitope expression on a chimaeric poliovirus vaccine vector

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Human immunodeficiency virus" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Human immunodeficiency virus" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Human immunodeficiency virus
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021